Intravitreal autologous plasmin as a therapeutic modality for diffuse diabetic macular edema

OBJECTIVES: To evaluate the outcome of vitreolysis using intravitreal autologous plasmin (IAP) injection as a sole therapeutic modality for patients with diffuse diabetic macular edema in comparison to triamcinolone acetonide (TA). PATIENTS AND METHODS: The study included 50 diabetic patients, 18 ma...

Descripción completa

Detalles Bibliográficos
Autor principal: Elsawy, Moataz F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526912/
https://www.ncbi.nlm.nih.gov/pubmed/23271887
http://dx.doi.org/10.2147/OPTH.S36609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526912/
https://www.ncbi.nlm.nih.gov/pubmed/23271887
http://dx.doi.org/10.2147/OPTH.S36609

Ejemplares similares